Translational Drug Development
Research, E Shea BLVD, Scottsdale, , 85259, Arizona, 13208, United States, 51-200 Employees
Phone Number: 60********
Who is TRANSLATIONAL DRUG DEVELOPMENT
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening disea...
Read More
-
Headquarters: 13208 E Shea BLVD, Scottsdale, Arizona, 85259, United States
-
Date Founded: 2003
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Research
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from TRANSLATIONAL DRUG DEVELOPMENT
Translational Drug Development Org Chart and Mapping
Email
Phone
Similar Companies to Translational Drug Development
PPD
-
10001+
-
$ 1 Billion and Over
Worldwide Clinical Trials
-
1001-5000
-
$ 500 Million to 1 Billion
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Translational Drug Development
Answer: Translational Drug Development's headquarters are located at E Shea BLVD, Scottsdale, , 85259, Arizona, 13208, United States
Answer: Translational Drug Development's phone number is 60********
Answer: Translational Drug Development's official website is https://td2inc.com
Answer: Translational Drug Development's revenue is $50 Million to $100 Million
Answer: Translational Drug Development's SIC: 2834
Answer: Translational Drug Development has 51-200 employees
Answer: Translational Drug Development is in Research
Answer: Translational Drug Development top competitors include: PPD , Worldwide Clinical Trials
Answer: Translational Drug Development contact info: Phone number: 60******** Website: https://td2inc.com
Answer: Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGens deep scientific expertise and approach to interrogating the omic drivers of disease is at the heart of TD2s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month